CLX vs UL: Clorox and Unilever PLC ADR compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- Unilever PLC ADR is the larger company, worth $135.0B, about 13.8 times Clorox.
- Clorox grew revenue faster over the last year (+0.1% vs -3.8%).
- On earnings, Clorox is the cheaper stock (13.1x vs 20.6x).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | CLX | UL |
|---|---|---|
| Market cap | $9.8B | $135.0B |
| Share price | $82.21 | $62.26 |
| Revenue (last fiscal year) | $7.1B | $50.5B |
| Free cash flow (last fiscal year) | $761M | $6.8B |
| Revenue growth, last year | +0.1% | -3.8% |
| Revenue growth per year, last 5 fiscal years | -0.8% | -0.9% |
| Operating margin | — | 17.9% |
| Net margin | 11.2% | 18.8% |
| Return on equity | — | 53.2% |
| P/E (trailing) | 13.1x | 20.6x |
| Price / free cash flow | 12.8x | 21.6x |
| EV / EBITDA | 10.1x | 11.7x |
| FCF growth the price implies | -0.83% | — |
| Dividend yield | 6.1% | 3.7% |
| Debt / equity | — | 3.15x |
| Fundamental grade | C | C |
| Superinvestors holding it | 4 | 9 |
| Insider purchases, last 12 months | 5 | 0 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
Clorox
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $7.3B | $945M | — |
| 2022 | $7.1B | $535M | — |
| 2023 | $7.4B | $930M | — |
| 2024 | $7.1B | $483M | — |
| 2025 | $7.1B | $761M | — |
Unilever PLC ADR
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $52.4B | $6.6B | 16.6% |
| 2022 | $60.1B | $5.6B | 17.9% |
| 2023 | $51.7B | $8.0B | 17.4% |
| 2024 | $52.5B | $7.9B | 16.8% |
| 2025 | $50.5B | $6.8B | 17.9% |
Where the revenue comes from
Clorox · by segments, 2026
Health and Wellness$2.7B40%
Household$1.8B27%
Lifestyle$1.1B17%
International$1.1B17%
Unilever PLC ADR · by segments, 2025
Personal Care$13.2B26%
Foods$12.9B26%
Beauty & Wellbeing$12.8B25%
Home Care$11.6B23%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CLX in InvestinglyQuestions
Which is bigger, Clorox or Unilever PLC ADR?
Unilever PLC ADR (UL), at $135.0B against $9.8B.
Is CLX or UL cheaper?
By trailing P/E, Clorox (13.1x) is cheaper than Unilever PLC ADR (20.6x). A lower multiple can also mean the market expects less growth.
Which grows faster, CLX or UL?
Clorox: revenue grew +0.1% over the last year, against -3.8%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.